As of 12:32pm ET
| +0.37 / +1.39%|
The 7 analysts offering 12-month price forecasts for Acorda Therapeutics Inc have a median target of 45.00, with a high estimate of 65.00 and a low estimate of 20.00. The median estimate represents a +66.54% increase from the last price of 27.02.
The current consensus among 9 polled investment analysts is to Buy stock in Acorda Therapeutics Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.